Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Retsevmo 80 mg hard capsules {equilateral_black_triangle}

Active Ingredient:
selpercatinib
Company:  
Eli Lilly and Company Limited See contact details
ATC code: 
L01EX22
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Live Chat HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 25 Oct 2024

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Eli Lilly and Company Limited
Company image
Address
Lilly House, Basing View, Basingstoke, Hampshire, RG21 4FA
Telephone
+44 (0)1256 315 000
WWW
https://www.lilly.com/uk/
Medical Information e-mail
[email protected]
Medical Information Website
https://www.lillymedical.co.uk/en-gb